Moreover, studies in patients with prostatic cancer have indicated that aspirin, a nonsteroidal anti-inflammatory drug used for prostatic inflammation, is able to increase the serum levels of IL-4 [45]. The gene discussed is IL4; the disease is prostate carcinoma.